Target intelligence / Profile preview

NADPH oxidase 2 (NOX2) (NOX2)

Target
NOX2
Molecular classification
Enzyme, Oxidoreductase
01

Overview

NADPH oxidase 2 (NOX2), also known as the phagocyte NADPH oxidase or cytochrome b-245, is a multi-subunit enzyme complex primarily located in the membranes of neutrophils and other phagocytes. Its primary biological function is the generation of reactive oxygen species (ROS), such as superoxide, through a process known as the respiratory burst, which is critical for the destruction of engulfed pathogens (Lambeth, 2004). The activation of NOX2 is a highly regulated process involving the phosphorylation of cytosolic subunits (such as p47phox, p67phox, and p40phox) by kinases like Protein Kinase C (PKC), followed by their translocation to the membrane-bound cytochrome b-245 complex (Fontayne et al., 2002). While essential for innate immunity, excessive or chronic ROS production by NOX2 is implicated in the pathogenesis of various inflammatory and cardiovascular diseases, including atherosclerosis, hypertension, and neurodegenerative disorders (Drummond et al., 2011). Therapeutic strategies targeting NOX2 aim to modulate ROS levels to prevent tissue damage, though complete inhibition carries the risk of inducing an immunodeficient state similar to Chronic Granulomatous Disease (CGD) (Bedard & Krause, 2007).

Other names
Cytochrome b-245 heavy chaingp91phoxCYBBPhagocyte NADPH oxidaseNADPH oxidase complex
02

Mechanism of action

Inhibition of the assembly or catalytic activity of the NADPH oxidase enzyme complex to prevent the transfer of electrons from NADPH to molecular oxygen, thereby reducing the production of superoxide anions.

03

Biological functions

Immune responseReactive oxygen species (ROS) productionPhagocytosisSignal transductionPathogen killing
04

Disease associations

InflammationCardiovascular diseaseInfectionAutoimmune diseaseNeurodegenerative diseaseChronic Granulomatous Disease
05

Safety considerations

Increased susceptibility to bacterial and fungal infectionsInduction of Chronic Granulomatous Disease (CGD) phenotypeImpaired wound healing
06

Interacting drugs

Apocynin

3 more in the full profile.

07

Biomarkers

Superoxide anion production levelsNitroblue tetrazolium (NBT) reductionDihydrorhodamine 123 (DHR) oxidationp47phox phosphorylation status

Beyond the preview

Go deeper on NADPH oxidase 2 (NOX2) (NOX2).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on NADPH oxidase 2 (NOX2) (NOX2).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call